Xenon Pharmaceuticals Non-Current Deferred Revenue (Quarterly) Analysis

Xenon Pharmaceuticals, Inc. (XENE)

39.98 -0.76 (-1.87%) USD | NASDAQ | Jan 16, 16:00

40.01 +0.03 (+0.08%) After-Hours: 20:00

View Non-Current Deferred Revenue (Quarterly) for XENE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	Upgrade
Aurinia Pharmaceuticals, Inc.	Upgrade
Edesa Biotech, Inc.	--
Lexaria Bioscience Corp.	--
ProMIS Neurosciences, Inc.	--